Apoptosis and heart failure: clinical relevance and therapeutic target

被引:78
作者
Garg, S
Narula, JA
Chandrashekhar, Y
机构
[1] Univ Calif Irvine, Med Ctr, Div Cardiol, Orange, CA 92868 USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[3] VAMC, Minneapolis, MN USA
[4] Univ Minnesota, Minneapolis, MN USA
关键词
review; apoptosis; heart failure; clinical therapy;
D O I
10.1016/j.yjmcc.2004.11.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure is the final common pathway of diverse ethiologies that are characterized by impaired systolic and/or diastolic function with high morbidity and mortality An integral part of pathogenesis of heart failure is myocyte loss. The traditionnal explanation for myocyte loss was cell necrosis but over the last decade, there has been a surge of evidence affirming the role of apoptosis in genesis of heart failure. Studies have raised apoptosis from a 'histologic curiosity' to an exciting 'clinical target' that can be modulated to attenuate the progression of heart failure. This review will focus on the clinical relevance of apoptosis in human and experimental heart failure and identify, some of the progress made in myocardial anti-apoptotic intervention. (C) 2004 Published by Elsevier Ltd.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 78 条
  • [1] Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure
    Abbate, A
    Biondi-Zoccai, GGL
    Bussani, R
    Dobrina, A
    Camilot, D
    Feroce, F
    Rossiello, R
    Baldi, F
    Silvestri, F
    Biasucci, LM
    Baldi, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (05) : 753 - 760
  • [2] Adams JW, 1999, CIRCULATION, V100, P282
  • [3] Enhanced Gαq signaling:: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
    Adams, JW
    Sakata, Y
    Davis, MG
    Sah, VP
    Wang, YB
    Liggett, SB
    Chien, KR
    Brown, JH
    Dorn, GW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) : 10140 - 10145
  • [4] *AHA, 2002, HEART STROK STAT UPD, P11
  • [5] Association between the severity of heart failure and the susceptibility of myocytes to apoptosis in patients with idiopathic dilated cardiomyopathy
    Akyürek, Ö
    Akyürek, N
    Sayin, T
    Dinçer, I
    Berkalp, B
    Akyol, G
    Özenci, M
    Oral, D
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 80 (01) : 29 - 36
  • [6] Apoptosis is prevented by administration of superoxide dismutase in dogs with reperfused myocardial infarction
    Ambrosio, G
    Zweier, JL
    Becker, LC
    [J]. BASIC RESEARCH IN CARDIOLOGY, 1998, 93 (02) : 94 - 96
  • [7] Aurintricarboxylic acid inhibits apoptosis and supports proliferation in a haemopoietic growth-factor dependent myeloid cell line
    Andrew, DJ
    Hay, AWM
    Evans, SW
    [J]. IMMUNOPHARMACOLOGY, 1999, 41 (01): : 1 - 10
  • [8] ARBUSTINI E, 2001, MED PATHOL
  • [9] Apoptosis and post-infarction left ventricular remodeling
    Baldi, A
    Abbate, A
    Bussani, R
    Patti, G
    Melfi, R
    Angelini, A
    Dobrina, A
    Rossiello, R
    Silvestri, F
    Baldi, F
    Di Sciascio, G
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (02) : 165 - 174
  • [10] Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure - A primary role of mechanical unloading underlying reverse remodeling
    Barbone, A
    Holmes, JW
    Heerdt, PM
    The', AHS
    Naka, Y
    Joshi, N
    Daines, M
    Marks, AR
    Oz, MC
    Burkhoff, D
    [J]. CIRCULATION, 2001, 104 (06) : 670 - 675